Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:APEN

Apollo Endosurgery (APEN) Stock Price, News & Analysis

Apollo Endosurgery logo

About Apollo Endosurgery Stock (NASDAQ:APEN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$9.87
$10.00
52-Week Range
N/A
Volume
1.66 million shs
Average Volume
1.43 million shs
Market Capitalization
$579.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive APEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apollo Endosurgery and its competitors with MarketBeat's FREE daily newsletter.

APEN Stock News Headlines

Apollo Endosurgery Stock Price History
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Apollo Pipes Ltd 531761
See More Headlines

APEN Stock Analysis - Frequently Asked Questions

Apollo Endosurgery, Inc. (NASDAQ:APEN) posted its quarterly earnings data on Sunday, October, 31st. The biotechnology company reported ($0.23) earnings per share for the quarter, beating analysts' consensus estimates of ($0.28) by $0.05. The biotechnology company earned $16.35 million during the quarter, compared to analysts' expectations of $16.20 million. Apollo Endosurgery had a negative net margin of 51.84% and a negative trailing twelve-month return on equity of 89.48%.
Read the conference call transcript
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Apollo Endosurgery investors own include Pfizer (PFE), Novavax (NVAX), NVIDIA (NVDA), Ocugen (OCGN), Canopy Growth (CGC), Inovio Pharmaceuticals (INO) and Meta Platforms (META).

Company Calendar

Last Earnings
10/31/2021
Today
7/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:APEN
CIK
1251769
Employees
202
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$39.84 million
Net Margins
-51.84%
Pretax Margin
-51.08%
Return on Equity
-89.48%
Return on Assets
-33.76%

Debt

Debt-to-Equity Ratio
1.04
Current Ratio
2.35
Quick Ratio
1.89

Sales & Book Value

Annual Sales
$76.86 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.69 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
57,972,000
Free Float
47,943,000
Market Cap
$579.72 million
Optionable
Not Optionable
Beta
2.31

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:APEN) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners